| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 15 |
| 1 | TIRZEPATIDE | 15 |
| 2 | TOCILIZUMAB | 12 |
| 3 | PREDNISONE | 9 |
| 4 | RISANKIZUMAB-RZAA | 9 |
| 5 | ADALIMUMAB | 8 |
| 6 | UPADACITINIB | 8 |
| 7 | ASPIRIN | 7 |
| 8 | ASPIRIN 325 MG | 7 |
| 9 | ASPIRIN 81 MG | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| 1 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 2 | LATANOPROSTENE BUNOD | 1 | 0.0009 |
| 3 | PSYLLIUM HUSK | 1 | 0.0007 |
| 4 | NETARSUDIL | 1 | 0.0005 |
| 5 | OSILODROSTAT | 1 | 0.0005 |
| 6 | ESTRADIOL, FOLLICULINUM, OOPHORINUM (SUIS) | 1 | 0.0004 |
| 7 | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | 1 | 0.0004 |
| 8 | FARICIMAB | 3 | 0.0003 |
| 9 | MAVACAMTEN | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 1 | Cardiac Myosin Inhibitor [EPC] | 2 | 0.0003 |
| 2 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 1 | 0.0003 |
| 3 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 4 | Interleukin-23 Antagonist [EPC] | 10 | 0.0001 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 12 | 0.0001 |
| 6 | GLP-1 Receptor Agonist [EPC] | 30 | 0.0001 |
| 7 | Interleukin-31 Receptor alpha Antagonist [EPC] | 1 | 0.0001 |
| 8 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 1 | 0.0001 |
| 9 | Nitrofuran Antibacterial [EPC] | 1 | 0.0001 |